Clonal Hematopoiesis in Patients Receiving Immune Checkpoint Inhibitor Therapy

被引：0
|
作者：
Singh, Abhay
Mencia-Trinchant, Nuria
Griffiths, Elizabeth A.
Gravina, Matthew
Tajammal, Rutaba
Faber, Mark G.
Nowak, Annmarie
Ernstoff, Marc S.
Yan, LunBiao
Herr, Megan M.
Hassane, Duane C.
Guzman, Monica L.
Wang, Eunice S.
Przespolewski, Amanda
Thota, Swapna
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-141617
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Immune Checkpoint Inhibitor Therapy and Associations with Clonal Hematopoiesis
    Singh, Abhay
    Trinchant, Nuria Mencia
    Mishra, Rahul
    Arora, Kirti
    Mehta, Smit
    Kuzmanovic, Teodora
    Nikoo, Maedeh Zokaei
    Singh, Inderpreet
    Przespolewski, Amanda C.
    Swaminathan, Mahesh
    Ernstoff, Marc S.
    Dy, Grace K.
    Yan, Lunbiao
    Sinha, Eti
    Sharma, Shruti
    Hassane, Duane C.
    Griffiths, Elizabeth A.
    Wang, Eunice
    Guzman, Monica L.
    Thota, Swapna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (20)
  • [2] Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy
    Shiuan, Eileen
    Beckermann, Kathryn E.
    Ozgun, Alpaslan
    Kelly, Ciara
    McKean, Meredith
    McQuade, Jennifer
    Thompson, Mary Ann
    Puzanov, Igor
    Greer, John P.
    Rapisuwon, Suthee
    Postow, Michael
    Davies, Michael A.
    Eroglu, Zeynep
    Johnson, Douglas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [3] Monitoring of thyroid function tests in patients receiving immune checkpoint inhibitor therapy
    Slattery, Timothy
    Sacks, Lori
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 24 - 24
  • [4] Renal Vasculitis and Pauci-immune Glomerulonephritis in Patients Receiving Immune Checkpoint Inhibitor Therapy
    Gallan, Alexander
    Alexander, Ellen
    Chang, Anthony
    Henriksen, Kammi
    MODERN PATHOLOGY, 2019, 32
  • [5] Renal Vasculitis and Pauci-immune Glomerulonephritis in Patients Receiving Immune Checkpoint Inhibitor Therapy
    Gallan, Alexander
    Alexander, Ellen
    Chang, Anthony
    Henriksen, Kammi
    LABORATORY INVESTIGATION, 2019, 99
  • [6] CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) IS AN INDEPENDENT RISK FACTOR FOR IMMUNE CHECKPOINT INHIBITOR MYOCARDITIS
    Chen, Nathan
    Martinez, Carlos Felipe Matute
    Jayakrishnan, Ritujith
    Jiang, Matthew
    Guajardo, Ana Ferrigno
    Vanoudenhove, Jennifer
    Im, Yunju
    Hwa, John
    Halene, Stephanie
    Kwan, Jennifer
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 2492 - 2492
  • [7] A New Risk Factor for Cardiovascular Events in Patients Receiving Immune Checkpoint Inhibitor Therapy?
    Thavendiranathan, Paaladinesh
    Sacher, Adrian
    JACC: CARDIOONCOLOGY, 2022, 4 (05): : 670 - 672
  • [8] Antibiotic use, clinical outcomes, and systemic immune biomarkers in patients receiving immune checkpoint inhibitor therapy
    von Itzstein, Mitchell S.
    Gonugunta, Amrit S.
    Sheffield, Thomas
    Homsi, Jade
    Dowell, Jonathan E.
    Koh, Andrew Y.
    Raj, Prithvi
    Fattah, Farjana
    Basava, Vijay S.
    Park, Jason Y.
    Popat, Vinita
    Saltarski, Jessica M.
    Gloria-McCutchen, Yvonne
    Hsiehchen, David
    Ostmeyer, Jared
    Khan, Shaheen
    Xie, Yang
    Li, Quan-Zhen
    Wakeland, Edward K.
    Gerber, David E.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 168 - 168
  • [9] Clonal hematopoiesis and differential outcomes after immune checkpoint blockade
    Hsiehchen, David
    Sfreddo, Hannah J.
    Zhao, Karena
    Han, Catherine Y.
    Morris, Luc G. T.
    CANCER CELL, 2022, 40 (10) : 1071 - 1072
  • [10] Cancer patients receiving immune checkpoint inhibitor therapy are at an increased risk for atherosclerotic cardiovascular disease
    Lutgens, Esther
    Seijkens, Tom T. P.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
12345